Matilda Holm

Publications
Public outreach and news

Articles

Article: CANCERS. 2023;15(14):3571
N-Glycomic Profiling of Microsatellite Unstable Colorectal Cancer
Ukkola I; Nummela P; Heiskanen A; Holm M; Zafar S; Kero M; Haglund C; Satomaa T; Kytola S; Ristimaki A
Article: CANCER RESEARCH. 2022;82(19):3549-3560
Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State.
Pitter KL; Grbovic-Huezo O; Joost S; Singhal A; Blum M; Wu K; Holm M; Ferrena A; Bhutkar A; Hudson A; Lecomte N; de Stanchina E; Chaligne R; Iacobuzio-Donahue CA; Pe'er D; Tammela T
Article: PLOS ONE. 2022;17(5):e0267967
Quantitative glycoproteomics of human milk and association with atopic disease
Holm M; Saraswat M; Joenvaara S; Seppo A; Looney RJM; Tohmola T; Renkonen J; Renkonen R; Jarvinen K
Article: PLOS ONE. 2022;17(8):e0272810
Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis
Holm M; Joenvaara S; Saraswat M; Tohmola T; Saarela T; Tenca A; Arola J; Renkonen R; Farkkila M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(48):30670-30678
Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma.
Grbovic-Huezo O; Pitter KL; Lecomte N; Saglimbeni J; Askan G; Holm M; Melchor JP; Chandwani R; Joshi S; Haglund C; Iacobuzio-Donahue CA; Chiosis G; Tammela T; Leach SD
Article: CANCER MEDICINE. 2020;9(14):5221-5234
Plasma protein expression differs between colorectal cancer patients depending on primary tumor location.
Holm M; Joenväärä S; Saraswat M; Tohmola T; Ristimäki A; Renkonen R; Haglund C
Article: TUMOR BIOLOGY. 2020;42(6):1010428320936410-101042832093641
Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival.
Holm M; Saraswat M; Joenväärä S; Seppänen H; Renkonen R; Haglund C
Article: PLOS ONE. 2020;15(6):e0234989
N-glycomic profiling of colorectal cancer according to tumor stage and location.
Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C
Article: ONCOLOGY. 2020;98(7):493-500
Preoperative Radiotherapy Leads to Significant Differences in the Plasma Protein Profile of Rectal Cancer Patients.
Holm M; Joenväärä S; Saraswat M; Tohmola T; Ristimäki A; Renkonen R; Haglund C
Article: PLOS ONE. 2020;15(11):e0239819
Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing
Holm M; Andersson E; Osterlund E; Ovissi A; Soveri L-M; Anttonen A-K; Kytola S; Aittomaki K; Osterlund P; Ristimaki A
Article: FASEB BIOADVANCES. 2019;1(12):723-730
Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome.
Holm M; Joenväärä S; Saraswat M; Mustonen H; Tohmola T; Ristimäki A; Renkonen R; Haglund C
Article: PLOS ONE. 2018;13(4):e0195354
Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
Holm M; Saraswat M; Joenväärä S; Ristimäki A; Haglund C; Renkonen R

Articles

News from KI

Events from KI